|By PR Newswire||
|January 17, 2014 09:30 AM EST||
CHICAGO, Jan. 17, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Stratasys (Nasdaq:SSYS-Free Report), 3D Systems (NYSE:DDD-Free Report), ExOne Company (Nasdaq:XONE-Free Report), Voxeljet (NYSE:VJET-Free Report) and Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN-Free Report).
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.
Here are highlights from Thursday's Analyst Blog:
3D Printing Stocks Decline
The stupendous run of the 3D printing solution providers such as Stratasys (Nasdaq:SSYS-Free Report), 3D Systems (NYSE:DDD-Free Report), The ExOne Company (Nasdaq:XONE-Free Report) in the previous year came to an abrupt halt after some of them provided lower-than-expected guidance.
In 2013, Stratasys, 3D systems and ExOne generated returns of 45.4%, 115.1% and 114.4%, respectively, compared to a decline of 8.3%, 4.7% and 9.1% in 2014, year-to-date. Another recently-listed 3D printing company Voxeljet (NYSE:VJET-Free Report) was down 5.4% year-to-date.
The major sell-off took place on Tuesday as ExOne lowered its fiscal 2013 revenue guidance and Stratasys provided a lower-than-expected fiscal 2014 forecast. Panic set in and almost all 3D printing stocks were affected.
Stratasys' 2014 guidance indicated that operating expenses would increase significantly due to the incremental investments in sales & marketing and research & development. Moreover, Stratasys expects second-half fiscal 2014 non-GAAP net income to be governed by the rate of adoption of its new products and changing schedules of operating expenses.
Encouragingly, Stratasys expects fiscal 2014 revenues to range between $660 million–$680 million, higher than the fiscal 2013 revenue forecast of $470 million to $490 million. Additionally, the company expects strong organic revenues. Despite these optimistic forecasts, the company's stock was downgraded to a Zacks Rank #5 (Strong Sell). This when accompanied by a 0.00% Earnings ESP does not indicate a favorable forecast for the current quarter.
Another stock that is in the news is ExOne which lowered its FY13 revenue guidance to a range of $40 million to $42 million from $48 million on account of deferment of machine sales to 2014. However, the company remained positive on organic top-line growth which is expected to be in the range of 40% to 50%.
In the trailing four quarters, ExOne posted an average 14.3% positive earnings surprise. However, for the current quarter, the company's Zacks Rank #3 (Hold) and Zacks Earnings ESP of 0.00% makes surprise prediction difficult.
The other two stocks, 3D Systems and Voxeljet, carry a Zacks Rank # 3 (Hold) and a Zacks Earnings ESP of 0.00%. Thus, we are taking a wait-and-see approach to the current quarter as regards these 3D printing stocks.
As such the 3D printing companies operate within a high-cost structure and any sort of disruption in the top line is likely to impact their overall results. Moreover, 3D printing is a relatively new concept and is likely to take time to gain popularity.
Nonetheless, the 3D printing market presents a favorable long-term opportunity as a large number of engineers, designers, architects and entrepreneurs are resorting to 3D solutions for their primary designing and product modeling. We therefore think that the adoption rate and cost control measures will be important factors determining the fortune of companies in this segment.
Prospects Bright at Alexion Pharma
Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN-Free Report) said at the JPMorgan Healthcare Conference that it is on track to deliver 36% and 41% year-over-year growth in revenues and earnings respectively in 2013. The revenue growth is attributable to strong sales of the biopharmaceutical company's sole marketed product Soliris. Soliris is available for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).
Alexion Pharma expects 2013 revenues in the range of $1.520–$1.530 billion. The company expects adjusted earnings for 2013 in the range of $3.02 to $3.04 per share. The company will provide detailed guidance for 2014 at its fourth quarter 2013 conference call later this month.
Alexion Pharma is expecting six product approvals within the time period of 2014 to 2018 including asfotase alfa (hypophosphatasia), ALXN 1101 (MoCD type A) and Soliris' label expansion. Asfotase alfa is expected to be approved by year end. This will reduce the company's dependence on Soliris for growth.
In a bid to expand, Alexion Pharma inked a deal with the privately held Moderna Therapeutics for the discovery and development of messenger ribo nucleic acid (mRNA) therapeutics to treat patients suffering from rare diseases. The drug discovery platform can expedite the development and manufacture of candidates for treating patients with rare diseases. Under the terms of the deal, Alexion will make an upfront payment of $100 million to Moderna for purchasing 10 product options to develop and commercialize therapies utilizing the mRNA platform. Alexion pharma, which has made a $25 million preferred equity investment in Moderna, will have to make milestone and royalty payments to the latter if situation arises.
We expect Alexion to deliver impressive fourth quarter 2013 revenues driven by strong Soliris sales in the PNH and aHUS indications.
Alexion Pharma carries a Zacks Rank #3 (Hold).
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today.
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros.
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
SOURCE Zacks Investment Research, Inc.
SYS-CON Events announced today that Catchpoint Systems, Inc., a provider of innovative web and infrastructure monitoring solutions, has been named “Silver Sponsor” of SYS-CON's DevOps Summit at 18th Cloud Expo New York, which will take place June 7-9, 2016, at the Javits Center in New York City, NY. Catchpoint is a leading Digital Performance Analytics company that provides unparalleled insight into customer-critical services to help consistently deliver an amazing customer experience. Designed ...
Feb. 27, 2017 05:45 PM EST Reads: 525
SYS-CON Events announced today that CA Technologies has been named “Platinum Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. CA Technologies helps customers succeed in a future where every business – from apparel to energy – is being rewritten by software. From ...
Feb. 27, 2017 05:30 PM EST Reads: 511
Tintri VM-aware storage is the simplest for virtualized applications and cloud. Organizations including GE, Toyota, United Healthcare, NASA and 6 of the Fortune 15 have said "No to LUNs." With Tintri they manage only virtual machines, in a fraction of the footprint and at far lower cost than conventional storage. Tintri offers the choice of all-flash or hybrid-flash platform, converged or stand-alone structure and any hypervisor. Rather than obsess with storage, leaders focus on the business app...
Feb. 27, 2017 05:30 PM EST Reads: 331
The financial services market is one of the most data-driven industries in the world, yet it’s bogged down by legacy CPU technologies that simply can’t keep up with the task of querying and visualizing billions of records. In his session at 20th Cloud Expo, Jared Parker, Director of Financial Services at Kinetica, will discuss how the advent of advanced in-database analytics on the GPU makes it possible to run sophisticated data science workloads on the same database that is housing the rich inf...
Feb. 27, 2017 05:15 PM EST Reads: 1,666
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm.
Feb. 27, 2017 05:15 PM EST Reads: 674
Ayehu provides IT Process Automation & Orchestration solutions for IT and Security professionals to identify and resolve critical incidents and enable rapid containment, eradication, and recovery from cyber security breaches. Ayehu provides customers greater control over IT infrastructure through automation. Ayehu solutions have been deployed by major enterprises worldwide, and currently, support thousands of IT processes across the globe. The company has offices in New York, California, and Isr...
Feb. 27, 2017 05:15 PM EST Reads: 602
LogMeIn has completed its previously disclosed merger with Citrix Systems, Inc.’s GetGo, Inc. subsidiary, a wholly owned subsidiary consisting of Citrix’s GoTo family of service offerings. The merger officially closed after market hours on January 31, 2017. Effected through a Reverse Morris Trust transaction, the merger brings together two of the preeminent players in cloud connectivity to instantly create one of the world’s top 10 public SaaS companies, and a market leader with the scale, resou...
Feb. 27, 2017 05:00 PM EST Reads: 345
In his keynote at 18th Cloud Expo, Andrew Keys, Co-Founder of ConsenSys Enterprise, provided an overview of the evolution of the Internet and the Database and the future of their combination – the Blockchain. Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life settle...
Feb. 27, 2017 04:45 PM EST Reads: 1,773
In his session at @ThingsExpo, Steve Wilkes, CTO and founder of Striim, will delve into four enterprise-scale, business-critical case studies where streaming analytics serves as the key to enabling real-time data integration and right-time insights in hybrid cloud, IoT, and fog computing environments. As part of this discussion, he will also present a demo based on its partnership with Fujitsu, highlighting their technologies in a healthcare IoT use-case. The demo showcases the tracking of patie...
Feb. 27, 2017 04:45 PM EST Reads: 1,434
The explosion of new web/cloud/IoT-based applications and the data they generate are transforming our world right before our eyes. In this rush to adopt these new technologies, organizations are often ignoring fundamental questions concerning who owns the data and failing to ask for permission to conduct invasive surveillance of their customers. Organizations that are not transparent about how their systems gather data telemetry without offering shared data ownership risk product rejection, regu...
Feb. 27, 2017 03:30 PM EST Reads: 2,284
The best way to leverage your Cloud Expo presence as a sponsor and exhibitor is to plan your news announcements around our events. The press covering Cloud Expo and @ThingsExpo will have access to these releases and will amplify your news announcements. More than two dozen Cloud companies either set deals at our shows or have announced their mergers and acquisitions at Cloud Expo. Product announcements during our show provide your company with the most reach through our targeted audiences.
Feb. 27, 2017 02:45 PM EST Reads: 2,600
SYS-CON Events announced today that Cloud Academy will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Cloud Academy is the industry’s most innovative, vendor-neutral cloud technology training platform. Cloud Academy provides continuous learning solutions for individuals and enterprise teams for Amazon Web Services, Microsoft Azure, Google Cloud Platform, and the most popular cloud computing technologies. Ge...
Feb. 27, 2017 02:30 PM EST Reads: 1,943
Cloud Expo, Inc. has announced today that Aruna Ravichandran, vice president of DevOps Product and Solutions Marketing at CA Technologies, has been named co-conference chair of DevOps at Cloud Expo 2017. The @DevOpsSummit at Cloud Expo New York will take place on June 6-8, 2017, at the Javits Center in New York City, New York, and @DevOpsSummit at Cloud Expo Silicon Valley will take place Oct. 31-Nov. 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Feb. 27, 2017 02:30 PM EST Reads: 2,313
"A lot of the enterprises that have been using our systems for many years are reaching out to the cloud - the public cloud, the private cloud and hybrid," stated Reuven Harrison, CTO and Co-Founder of Tufin, in this SYS-CON.tv interview at 16th Cloud Expo, held June 9-11, 2015, at the Javits Center in New York City.
Feb. 27, 2017 02:00 PM EST Reads: 4,234
In his keynote at 19th Cloud Expo, Sheng Liang, co-founder and CEO of Rancher Labs, discussed the technological advances and new business opportunities created by the rapid adoption of containers. With the success of Amazon Web Services (AWS) and various open source technologies used to build private clouds, cloud computing has become an essential component of IT strategy. However, users continue to face challenges in implementing clouds, as older technologies evolve and newer ones like Docker c...
Feb. 27, 2017 01:45 PM EST Reads: 1,774